The current evolution towards treating more complex femoropopliteal lesions as seen in the
renewed TASC II recommendations clearly reflects the continuous evolutions in …

Endovascular stent implantation was introduced to femoropopliteal procedures almost two
decades ago. Initial results with balloon-expandable stainless steel stents and self …

Drug-eluting stent (DES) technology was developed to prevent early thrombosis and late
luminal loss to potentially improve long-term patency rates. Although favorable DES results …

Peripheral arterial disease most commonly affects the femoropopliteal segment. Despite
enormous improvements in device and treatment technology the long-term patency rate and …

Although evidence supports that the performance of drug coated balloons seems to be
lesion complexity independent, it is quite clear that in long lesions, severe calcified lesions …

Purpose: To determine and compare the rates of in-stent restenosis, late clinical
deterioration, and stent fractures in nitinol stents versus Wallstents implanted for suboptimal …

Background Limited comparative data exist on different interventional strategies for
endovascular revascularization of complex femoropopliteal interventions. Objectives In this …

Purpose Advancements in the endovascular treatment of femoropopliteal atherosclerotic
lesions have led to treatment of more complex lesions, particularly long lesions. The aim of …

Background Endovascular approach to superficial femoral artery (SFA) disease, the most
common cause of symptomatic peripheral arterial disease, remains fraught with high failure …

Background To evaluate outcomes of superficial femoral artery (SFA) stenting with Boston
Scientific Innova stent system (Boston Scientific Corporation Place, Natick, Massachusetts …